-

Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) breached their fiduciary duties to Regeneron and its shareholders. If you are a Regeneron shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

Scott+Scott is investigating whether Regeneron’s board of directors or senior management failed to manage Regeneron in an acceptable manner, in breach of their fiduciary duties to Regeneron, and whether Regeneron has suffered damages as a result.

In January 2017, Regeneron received a subpoena from the U.S. Attorney’s Office for the District of Massachusetts regarding violations of federal anti-kickback statutes concerning use of patient-assistance funds to encourage doctors to prescribe certain of Regeneron’s drugs over less-expensive competitors.

In September 2019, Regeneron received a civil investigative demand from the U.S. Department of Justice pursuant to the federal False Claims Act investigating separate violations of federal anti-kickback statutes.

On June 24, 2020, federal prosecutors in Massachusetts filed suit against Regeneron, claiming violations of federal anti-kickback statutes.

What You Can Do

If you are a Regeneron shareholder, you may have legal claims against Regeneron’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Ohio, and Virginia.

Attorney Advertising

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:REGN

Release Summary
Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharma, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)
Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, NY, New York 10169
(844) 818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Cardinal Infrastructure Group Inc. (NASDAQ: CDNL)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, alerts investors that it is investigating potential violations of U.S. federal securities laws involving Cardinal Infrastructure Group Inc. (NASDAQ: CDNL).CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTIONWhat is Cardinal Infrastructure?Cardinal Infrastructure is a North Carolina-based infrastructure construction company specializing in under...

SIX FLAGS ENTERTAINMENT CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Six Flags Entertainment Corporation’s Directors and Officers for Breach of Fiduciary Duties – FUN

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Six Flags Entertainment Corporation (NYSE: FUN) failed to manage Six Flags in an acceptable manner, breaching their fiduciary duties to Six Flags, and whether Six Flags and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On October 12, 2026, a man died after bein...

BOSTON SCIENTIFIC CORPORATION INVESTOR ALERT:  Scott+Scott Attorneys at Law LLP Investigates Boston Scientific Corporation’s Directors and Officers for Breach of Fiduciary Duties – BSX

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 4, 2026, B...
Back to Newsroom